ABEONA THERAPEUTICS INC's ticker is ABEO and the CUSIP is 00289Y107. A total of 73 filers reported holding ABEONA THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is 0.03 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $175,000 | 0.0% | 0 | -100.0% | 0.01% | -16.7% |
Q2 2022 | $175,000 | 0.0% | 10,000 | 0.0% | 0.01% | +200.0% |
Q1 2022 | $175,000 | +136.5% | 10,000 | 0.0% | 0.00% | -80.0% |
Q1 2019 | $74,000 | +5.7% | 10,000 | 0.0% | 0.01% | +150.0% |
Q4 2018 | $70,000 | -45.3% | 10,000 | 0.0% | 0.00% | -20.0% |
Q3 2018 | $128,000 | -20.0% | 10,000 | 0.0% | 0.01% | -28.6% |
Q2 2018 | $160,000 | -15.8% | 10,000 | -16.7% | 0.01% | -22.2% |
Q1 2018 | $190,000 | 0.0% | 12,000 | 0.0% | 0.01% | 0.0% |
Q4 2017 | $190,000 | -55.4% | 12,000 | -52.0% | 0.01% | -47.1% |
Q3 2017 | $426,000 | +166.2% | 25,004 | 0.0% | 0.02% | +142.9% |
Q2 2017 | $160,000 | +28.0% | 25,004 | 0.0% | 0.01% | +40.0% |
Q1 2017 | $125,000 | +3.3% | 25,004 | 0.0% | 0.01% | -16.7% |
Q4 2016 | $121,000 | -19.3% | 25,004 | 0.0% | 0.01% | -25.0% |
Q3 2016 | $150,000 | +154.2% | 25,004 | 0.0% | 0.01% | +166.7% |
Q2 2016 | $59,000 | -20.3% | 25,004 | +150.0% | 0.00% | -70.0% |
Q1 2016 | $74,000 | -11.9% | 10,000 | -60.0% | 0.01% | +66.7% |
Q4 2015 | $84,000 | – | 25,004 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Knoll Capital Management, LLC | 1,359,767 | $3,481,000 | 1.41% |
DAFNA Capital Management LLC | 181,818 | $465,000 | 0.40% |
Perceptive Advisors | 1,762,881 | $4,512,000 | 0.40% |
SPHERA FUNDS MANAGEMENT LTD. | 468,050 | $1,198,000 | 0.26% |
Soros Fund Management | 1,462,122 | $3,743,000 | 0.08% |
SABBY MANAGEMENT, LLC | 334,108 | $855,000 | 0.04% |
KLCM Advisors, Inc. | 28,612 | $73,000 | 0.02% |
CAMBRIDGE TRUST CO | 65,414 | $167,000 | 0.01% |
PRELUDE CAPITAL MANAGEMENT, LLC | 35,400 | $91,000 | 0.01% |
IFP Advisors, Inc | 10,000 | $74,000 | 0.01% |